As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.
By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.
In this program, you will hear lessons learned from startup CEOs who have successfully sold their companies. You’ll hear about what they did well and what they wish they did differently, with additional input from major acquirers. The presentation is based on recent interviews with over 30 CEOs and acquirers, as well as the personal experiences of the presenters.
Â
This half-day program will cover:
Â
• How to build your company to ensure it is exit-ready
• Timing options for selling a company
• How to start and run a successful M&A process
Â
The presentation will be followed by one-on-one mentoring sessions (30 minutes each), providing tailored advice to ventures. If interested, please fill out the details in the registration form.
Tim has broad market experience and a deep technical background, having served in various executive roles at small, medium and large high-tech companies. Tim served on the buy-side M&A team at MDA, one of Canada’s largest technology firms, and has been involved in over a dozen buy-side and sell-side transactions. Tim is a founder and Managing Partner of Aqua M&A.Tim has broad market experience and a deep technical background, having served in various executive roles at small, medium and large high-tech companies. Tim served on the buy-side M&A team at MacDonald Dettwiler and Associates, one of Canada’s largest technology firms, and has been involved in over 10 buy-side and sell-side transactions.
Andy is a serial entrepreneur, having founded 8 advanced technology startups. Andy was a founder of the entrepreneurship program at the University of British Columbia (e@UBC), where he helped launch over 36 technology and life sciences companies in just 3 years. Andy has served on numerous tech industry boards, and has been selling advanced technology companies for more than 20 years. Andy is a founder and Managing Partner of Aqua M&A.
• 76% of all tech and life science exits occur prior to Series A financings
• It's critical to have an exit strategy from the beginning to be properly positioned and prepared when the time comes
• Attendees will get practical advice on actions they can take from their startup’s early days to prepare themselves for a successful exit in the future
Â
About Aqua
Aqua’s team has over 75 years of executive leadership experience with $2.5 B in M&A transactions. Managing partners Andy Talbot and Tim Botham will share their first-hand experience and research so that you can avoid common mistakes and set your company up today for a successful acquisition in the future.Â
